Neoadjuvant chemotherapy in breast cancer

Steinberg Sm, Swain Sm, Danforth Dn, Bader J, Lampert M, Egan E, McDonald H, Lippman Me, Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. American Surgeon. ,vol. 56, pp. 6- 11 ,(1990)

Z Baloch, A J Prestipino, U L Seinige, B A Mason, D M Sataloff, C P Lieber, Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. Journal of The American College of Surgeons. ,vol. 180, pp. 297- 306 ,(1995)

Eşmen Baltali, M Kadri Altundağ, Demir Ali Onat, Osman Abbasoğlu, Yavuz Özişik, Nilüfer Güler, Lale Atahan, Uğur Berberoğlu, Mehmet Altinok, Ismet Baran, İsmail Çelik, Gülten Tekuzman, Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: a preliminary report. Tumori. ,vol. 88, pp. 474- 477 ,(2002) , 10.1177/030089160208800608

J-Y Pierga, E Mouret, V Diéras, V Laurence, P Beuzeboc, T Dorval, T Palangié, M Jouve, A Vincent-Salomon, S Scholl, J-M Extra, B Asselain, P Pouillart, Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. British Journal of Cancer. ,vol. 83, pp. 1480- 1487 ,(2000) , 10.1054/BJOC.2000.1461

Jens-Uwe Blohmer, Augustinos Harjanto Tulusan, Christian Jackisch, Manfred Kaufmann, Gunter von Minckwitz, Serban Dan Costa, Wolfgang Eiermann, Maximized Reduction of Primary Breast Tumor Size Using Preoperative Chemotherapy With Doxorubicin and Docetaxel Journal of Clinical Oncology. ,vol. 17, pp. 1999- 2005 ,(1999) , 10.1200/JCO.1999.17.7.1999

Mario De Lena, Roberto Zucali, Giovanni Viganotti, Pinuccia Valagussa, Gianni Bonadonna, Combined Chemotherapy-Radiotherapy Approach in Locally Advanced (T3b-T4) Breast Cancer Cancer Chemotherapy and Pharmacology. ,vol. 1, pp. 53- 59 ,(1978) , 10.1007/BF00253147

P. C. Willsher, S. E. Pinder, S. Y. Chan, Robert Ian Nicholson, Julia Margaret Wendy Gee, J. F. R. Robertson, R. W. Blamey, I. O. Ellis, C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer. Anticancer Research. ,vol. 18, pp. 3695- 3698 ,(1998)

Tara M. Breslin, Lisa Cohen, Aysegul Sahin, Jason B. Fleming, Henry M. Kuerer, Lisa A. Newman, Ebrahim S. Delpassand, Rosalyn House, Frederick C. Ames, Barry W. Feig, Merrick I. Ross, S. Eva Singletary, Aman U. Buzdar, Gabriel N. Hortobagyi, Kelly K. Hunt, Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer Journal of Clinical Oncology. ,vol. 18, pp. 3480- 3486 ,(2000) , 10.1200/JCO.2000.18.20.3480

J. Chang, T. J. Powles, D. C. Allred, S. E. Ashley, G. M. Clark, A. Makris, L. Assersohn, R. K. Gregory, C. K. Osborne, M. Dowsett, Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 3058- 3063 ,(1999) , 10.1200/JCO.1999.17.10.3058

G Bonadonna, P Valagussa, C Brambilla, L Ferrari, A Moliterni, M Terenziani, M Zambetti, Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. Journal of Clinical Oncology. ,vol. 16, pp. 93- 100 ,(1998) , 10.1200/JCO.1998.16.1.93